Skip to Content

ASCO 2019: Proteomics analysis discovers biomarkers in serum months to years before small cell lung cancer

This is one of the first large-scale proteomics screening studies of pre-diagnostic serum of future small-cell lung cancer (SCLC) patients The results indicate that differential levels of a few proteins in serum may help detecting SCLC 2 months to 5 years prior to clinical diagnosis.

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top